1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsPublic Health Intervention Development Scheme (PHIND) is sponsored by Medical Research Council (MRC). Supports early stages of development for innovative new interventions that address an important UK or global public health issue.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Public Health Intervention Development (PHIND) – UKRI Funding opportunity: Public Health Intervention Development (PHIND) Medical Research Council (MRC) 25 January 2024 9:00am UK time 19 March 2024 4:00pm UK time Last updated: 21 November 2025 - see all updates Apply for funding for the early-stage development of an intervention that seeks to address a UK or global public health challenge.
You must be a researcher employed by an eligible research organisation. MRC will fund up to £150,000, for a maximum of 18 months. Funds requested by UK research organisations will be funded at 80% of the full economic cost, in which case the full economic cost of your project can be up to £187,500.
Overseas costs will be funded at 100% of the full economic cost. Before applying for funding, check the Eligibility of your organisation . For full details, visit Eligibility as an individual .
To be eligible to apply for this opportunity you must: show that you will direct the project and be actively engaged in the work focus your application within the science area of early-stage development of interventions that seek to address either UK or global public health challenges For applicants who do not have a contract of employment for the duration of the proposed project, by submitting an application the research organisation is confirming: contracts will be extended beyond the end date of the project appropriate laboratory space and access to facilities to carry out the research will be provided all necessary support for the project and the applicants will be provided, including mentorship and career development for early career researchers You can include international applicants as project co-leads if they provide expertise not available in the UK and make a major intellectual contribution to the design or conduct of the project.
You must justify in your application why their expertise is required, see ‘Applicant and team capability to deliver’. Equality, diversity and inclusion We are committed to achieving equality of opportunity for all funding applicants. We encourage applications from a diverse range of researchers.
We support people to work in a way that suits their personal circumstances. This includes: support for people with caring responsibilities alternative working patterns Find out more about equality, diversity and inclusion at UKRI . We are looking to support the early-stage development of interventions that seek to address either UK or global public health challenges.
This might include qualitative and quantitative primary research and the development of theory and logic models. However, emphasis should be placed on developing the intervention. This funding opportunity supports the incorporation of systems thinking in addressing public health challenges.
It is justifiable to focus on just aspect of a system as long as the wider systems context is recognised, for example, in the framework for evaluation. It also strongly encourages the use of interdisciplinary teams and co-production with users and other relevant stakeholders, such as policy makers. Population level interventions, with a focus on non-health care settings.
Examples of the focus of health-related population level interventions include: For the purposes of this funding opportunity, ‘population’ is defined as groups of individuals for which an intervention may subsequently be delivered and evaluated.
For example, this includes organisations such as schools, prisons and workplaces, or settings such as: Projects should demonstrate potential for improved health of general, high-risk or vulnerable populations. The creation of new interventions, where active components of existing interventions are combined to create a new intervention, is allowable within the scope.
The following activities are not within the scope of this funding opportunity: interventions treating clinical conditions or improving health services delivery standalone systematic reviews and meta-analyses standalone feasibility studies and pilot studies the wholesale transfer of a proven intervention to a new context, setting or target population You should address the following points about the proposed intervention, including: a clear theory behind its mechanism of action an indication of its forms and functions its likely components and their inter-relationships its continued refinement and sustainability The application should demonstrate a pathway to further development and evaluation of the intervention, and criteria for its progression to the next stage of development.
Engagement of potential commissioners and users of an intervention is often crucial to its potential success. You should be able to identify potential beneficiaries of your intervention, who would be delivering the intervention and who would commission it.
Your application will be strengthened by demonstrating that users and the target population will be willing to participate in the development study (and potentially further testing and evaluation). It may be helpful to refer to the MRC and National Institute for Health and Care Research (NIHR) guidance for developing and evaluating complex interventions .
This supports the development or identification, feasibility testing, evaluation and implementation of complex interventions. We will fund projects lasting up to 18 months. For information, MRC has previously funded awards with a shorter duration of eight and 10 months, however, successful awards typically span anywhere from 12 to 18 months in duration.
The full economic cost of your project can be up to a maximum of £187,500, however, you should note that MRC will only fund a maximum £150,000 per application.
You can request funding for costs such as: a contribution to the salary of the principal investigator and co-investigators support for other posts such as research and technical data preservation, data sharing and dissemination costs estates and indirect costs A limited amount (approximately 15%) of the overall cost may be allocated to some acceptability and feasibility research, to: further develop the intervention underpin further work to help the case for a future grant application You can also request costs for work to be undertaken at international organisations by international project co-leads.
We will fund 100% of the full economic cost. The total of such costs requested for international applicants from developed countries (those not on the OECD DAC List of ODA Recipients ), India and China must not exceed 30% of the total resources requested. There is no cap on costs requested for international applicants from DAC list countries.
For more information on international costs and what we will and will not fund see costs we fund overseas and the Collaborate with Researchers in Norway guidance .
research involving randomised trials or clinical interventions costs for PhD studentships funding to use as a ‘bridge’ between grants time spent developing applications for further funding You may include project partners that will support your research project through cash or in-kind contributions, such as: Each project partner must provide a statement of support.
If your application involves industry partners , they must provide additional information if the team project partner falls within the industry collaboration framework . Find out more about subcontractors and dual roles .
Who cannot be included as a team project partner The individual named as the contact for the project partner organisation cannot also be a named applicant, such as all those with a role of ‘investigator’ and any other named member of staff.
International collaboration If your application includes international applicants, project partners or collaborators, visit UKRI’s trusted research and innovation for more information on effective international collaboration. Find out about getting funding for international collaboration .
The project lead is responsible for completing the application process on the UK Research and Innovation (UKRI) Funding Service, but we expect all team members and project partners to contribute to the application. If the lead research organisation is an NHS organisation, check it is available in the Funding Service.
You are encouraged to check this early as there may be additional steps for the organisation to be set up before you can apply. The project lead is responsible for completing the application process on the Funding Service, but we expect all team members and project partners to contribute to the application. Only the lead research organisation can submit an application to UKRI.
Select ‘Start application’ near the beginning of this Funding finder page. Confirm you are the project lead. Please allow at least 10 working days for your organisation to be added to the Funding Service.
Answer questions directly in the text boxes. You can save your answers and come back to complete them or work offline and return to copy and paste your answers. If we need you to upload a document, follow the upload instructions in the Funding Service.
All questions and assessment criteria are listed in the How to apply section on this Funding finder page. Allow enough time to check your application in ‘read-only’ view before sending to your research office. Send the completed application to your research office for checking.
They will return it to you if it needs editing. Your research office will submit the completed and checked application to UKRI. Where indicated, you can also demonstrate elements of your responses in visual form if relevant.
If using visual elements, you must: use images sparingly and only to convey important information that cannot easily be put into words insert each new image onto a new line provide a descriptive legend for each image immediately underneath it (this counts towards your word limit) files must be smaller than 5MB and in JPEG, JPG, JPE, JFI, JIF, JFIF, PNG, GIF, BMP or WEBP format Watch our research office webinars about the new Funding Service .
For more guidance on the Funding Service, see: how applicants use the Funding Service how research offices use the Funding Service how reviewers use the Funding Service MRC must receive your application by 19 March 2024 at 4. 00pm UK time. You will not be able to apply after this time.
Make sure you are aware of and follow any internal institutional deadlines. Following the close of the funding opportunity, your application cannot be changed and applications will not be returned for amendment. If your application does not follow the guidance, it may be rejected.
MRC, as part of UKRI, will need to collect some personal information to manage your Funding Service account and the registration of your funding applications. We will handle personal data in line with UK data protection legislation and manage it securely. For more information, including how to exercise your rights, read our privacy notice .
MRC, as part of UKRI, will publish the outcomes of this funding opportunity at Public health intervention development scheme funding decisions . If your application is successful, we will publish some personal information on the UKRI Gateway to Research . In plain English, provide a summary we can use to identify the most suitable experts to assess your application.
We may make this summary publicly available on external-facing websites, so make it suitable for a variety of readers, for example: the wider research community Guidance for writing a summary Clearly describe your proposed work in terms of: the public health challenge the project addresses and its potential impact aims and study objectives potential applications and benefits List the key members of your team and assign them roles from the following: project co-lead (UK) (PcL) project co-lead (international) (PcL (I)) professional enabling staff research and innovation associate Only list one individual as project lead.
MRC policy only allows one person to be named project lead within your Public Health Intervention Development (PHIND) application. Applications that include more than one project lead will be rejected by MRC. Find out more about UKRI’s core team roles in funding applications .
What are you hoping to achieve with your proposed work?
What the assessors are looking for in your response Explain how your proposed work: is of excellent quality and importance within or beyond the field(s) or area(s) has the potential to advance current understanding, or generate new knowledge, thinking or discovery within or beyond the field or area is timely given current trends, context, and needs impacts world-leading research, society, the economy, or the environment Within the ‘Vision’ section we also expect you to: identify the potential direct or indirect benefits and who the beneficiaries might be describe the strategic public health priorities and public health outcomes being addressed explain the evidence gap being addressed with this intervention, referring to relevant literature and what is already known, including what has previously been tested and why a new intervention is needed.
Please reflect on: You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service. How are you going to deliver your proposed work?
What the assessors are looking for in your response Explain how you have designed your approach so that it: is effective and appropriate to achieve your objectives is feasible, and comprehensively identifies any risks to delivery and how they will be managed uses a clearly written and transparent methodology (if applicable) summarises the previous work and describes how this will be built upon and progressed (if applicable) will maximise translation of outputs into outcomes and impacts describes how your, and if applicable your team’s, research environment (in terms of the place and relevance to the project) will contribute to the success of the work Within the ‘Approach’ section we also expect you to: fully justify the target population identified in your application, with clear consideration of the potential for differences according to: provide the expected number of focus groups, participants, people completing a survey and so on, where applicable clearly describe how the intervention content will be developed from the data collected, including justification for the approach taken highlight any novel aspects of this project or proposed approach outline how co-production with relevant stakeholders will be embedded into development of the intervention and throughout design and delivery of the study discuss how systems thinking has been applied to the design of the research study and ensure you evaluate the potential for unintended consequences, both positive and negative, explaining what you could put in place to mitigate risks and capture positive outcomes using a systems approach provide a project plan including milestones and timelines, in the form of an embedded Gantt chart or similar (mandatory) you also have the option to provide an embedded logic model to describe the anticipated mechanism of action, delivery, key components and their inter-relationships, outputs and outcomes of the intervention (optional) You may demonstrate elements of your responses in visual form if relevant.
Further details are provided in the Funding Service. Please do not use the Gantt chart to include information which should be detailed in the other sections of your application.
All applicants should be aware of the following: if your application does not include a project plan, your application will be rejected MRC will not be returning applications for amendment and will not accept late submissions successful PHIND applications clearly describe robust methods. For example, if you are using focus groups, specify the number of sessions that will be involved and justify group or sample sizes.
You should also define the selection criteria and recruitment strategy for your study participants What are the next steps for the development and evaluation of the intervention after the proposed PHIND project has been completed?
What the assessors are looking for in your response This question refers to future development and evaluation phases that would be informed by, or could lead on from, the proposed intervention development study. Include criteria for progression, the pathway to the next stage of evaluation and give an indication of what the intervention would likely involve.
It’s important to demonstrate: the pathway to the next stage of intervention development and evaluation what the intervention would likely involve, such as the type and format of the intervention, clearly describing the system context, where applicable Be as clear as possible about the future plans, including an outline of the design of a full-scale evaluation.
While you’re not expected to know the outcome of your research, a strong application will provide: an indication of the anticipated intervention’s form and function (for example, specifying that you intend to develop an online alcohol reduction programme would give the panel a clearer picture of what you envisage than simply referring to an educational resource) relevant programme theory to underpin and explain the intervention and its likely effects how the proposed research will feed into the development and refinement of the intervention and inform whether it is likely to be affordable and feasible to deliver Not all PHIND projects will necessarily be developed into feasible interventions and high-risk high-impact projects are encouraged.
Either way, results will be valuable for informing future research and should be appropriately disseminated. You should also detail the criteria you’ll use to determine whether the project should progress to the next stage of evaluation. This may be related to uptake of the intervention, its feasibility or scalability, or practicality of delivery.
It’s not essential to provide figures but you should give the panel an indication of what you’ll be looking for. Applicant and team capability to deliver Why are you the right individual or team to successfully deliver the proposed work?
What the assessors are looking for in your response Evidence of how you, and if relevant your team, have: the relevant experience (appropriate to career stage) to deliver the proposed work the right balance of skills and expertise to cover the proposed work the appropriate leadership and management skills to deliver the work and your approach to develop others contributed to developing a positive research environment and wider community You may demonstrate elements of your responses in visual form if relevant.
Further details are provided in the service. The word count for this section is 1,500 words: 1,000 words to be used for R4RI modules and, if necessary, a further 500 words for Additions.
Use the Résumé for Research and Innovation (R4RI) format to showcase the range of relevant skills you and, if relevant, your team (project and project co-leads, researchers, technicians, specialists, partners and so on) have and how this will help deliver the proposed work. You can include individuals’ specific achievements but only choose past contributions that best evidence their ability to deliver this work.
Complete this section using the R4RI module headings listed. Use each heading once and include a response for the whole team, see the UKRI guidance on R4RI .
You should consider how to balance your answer, and emphasise where appropriate the key skills each team member brings: contributions to the generation of new ideas, tools, methodologies, or knowledge the development of others and maintenance of effective working relationships contributions to the wider research and innovation community contributions to broader research or innovation users and audiences and towards wider societal benefit Provide any further details relevant to your application.
This section is optional and can be up to 500 words. You should not use it to describe additional skills, experiences, or outputs, but you can use it to describe any factors that provide context for the rest of your R4RI (for example, details of career breaks if you wish to disclose them). Complete this as a narrative.
Do not format it like a CV. For full details, see Eligibility as an individual . Data management and sharing How will you manage and share data collected or acquired through the proposed research?
What the assessors are looking for in your response Provide a data management plan which should clearly detail how you will comply with MRC’s published data management and sharing policies , which includes detailed guidance notes. Provide your response following the MRC data management plan template .
The length of your plan will vary depending on the type of study being undertaken: population cohorts; longitudinal studies; genetic, omics and imaging data; biobanks, and other collections that are potentially a rich resource for the wider research community: maximum of 1,500 words all other research, less complex, the plan may be as short as 500 words List the references you have used to support your application What the assessors are looking for in your response You should include all references in this section of the application, and not in the rest of the application questions.
You should not include any other information in this section. We advise you not to include hyperlinks, as assessors are not obliged to access the information they lead to or consider it in their assessment of your application. If linking to web resources, to maintain the information’s integrity, include persistent identifiers (such as digital object identifiers) where possible.
You must not include links to web resources to extend your application. Add details about any project partners’ contributions. If there are no project partners, you can indicate this on the Funding Service.
A project partner is a collaborating organisation who will have an integral role in the proposed research, for example a charity partner or, if applicable, a supplier of the project intervention. Project partners do not include project co-leads. This may include direct (cash) or indirect (in-kind) contributions such as expertise, staff time or use of facilities.
Important note: If your application includes industry project partners, you will also need to complete the Industry Collaboration Framework (ICF) section. Find out more about ICF . You must ensure that any third party individual or organisation you include within the Funding Service as a project partner, also provides you with a supporting email or letter of support (see next section ‘Project partners: letters or emails of support’).
The individual (including their organisation) named as the project partner contact, cannot also be included within your application as an applicant, such as project lead or any other core team role . You cannot include a different department based within the same organisation as a member of your core team, as a project partner.
Add the following project partner details: the organisation name (searchable via a drop-down list or enter the organisation’s details manually, as applicable) the project partner contact name and email address the type of contribution (direct or in-direct) and its monetary value If there are specific circumstances where project partners do require funding for minor costs such as travel and subsistence (these project partner costs should be claimed and justified within the resources and costs section of your application).
For audit purposes, UKRI requires formal collaboration agreements to be put in place if an award is made. If an individual or organisation outside the core team is responsible for recruitment of people as research participants or providing human tissue for this project, list them as a project partner.
Important information when completing the project partners section within the Funding Service When completing your application in the Funding Service, if you discover that you have entered project partner information incorrectly and you have saved the entry, you should remove the specific project partner record and re-add it with the correct information.
Project partners: letters or emails of support Upload a single PDF containing the letters or emails of support from each partner you named in the ‘Project partner’ section. If you do not have any project partners, you will be able to indicate this in the Funding Service.
What supporting statements we are looking for Important note: MRC are only looking for you to provide letters or emails of support from the following: a third party organisation You must ensure that any third party project partners providing a supporting document, are also added to the ‘Project partners’ section within the Funding Service.
For audit purposes, UKRI requires formal collaboration agreements to be put in place if an award is made. What supporting statements we are not looking for MRC are not looking for you to provide any supporting emails or letters related to any individual or organisation already included within your application (this includes other departments within the same organisation).
Any individual or organisation included in your application with a core team role cannot also be a project partner. Check the opportunity specific roles available in the core team section for the definitive list.
Do not include any additional documents, email communications or any other type of information we have not requested, including supporting statements (letters or emails), simply expressing supportive opinions (we only expect to see emails or letters of support from third party project partners uploaded to this section). If you include any information not requested by MRC your application will be rejected.
Supporting document guidance for third party project partners Each third party project partner supporting letter or email you provide, should: be no more than two A4 pages confirm the partner’s commitment to the project clearly explain the value, relevance, and possible benefits of the work to them describe any additional value that they bring to the project include the name of the project partner organisation and contact information (this should match the partner contact and organisation name details you must add to the separate ‘Project partners’ application section) Project partners letters and emails of support are not required to be on headed paper or include handwritten signatures (electronic signatures are acceptable from the nominated partner contact).
Project partner responsibility for the recruitment of people If the project partner is responsible for the recruitment of people as research participants or providing human tissue their email or letter of support should include: agreement that the project partner will recruit the participants or provide tissue confirmation that what is being supplied is suitable for the proposed work confirmation that the quantity of tissue being supplied is suitable, but not excessive for achieving meaningful results (if applicable) Multiple project partners If you have multiple project partners, you should: ensure each separate email or letter of support does not exceed two pages of A4 consolidate all the supporting documents provided by each project partner into a single PDF file before uploading ensure the PDF does not exceed the maximum file size of 8MB For the file name, use the unique Funding Service number the system gives you when you create an application, followed by the words ‘Project partner’.
The Funding Service will provide document upload details when you apply. Industry collaboration framework (ICF) Does your application include industry project partners? What the assessors are looking for in your response If industry collaboration does not apply to any of your project partners, or you don’t have any project partners, simply add ‘N/A’ into the text box.
If your research project involves collaboration between an academic organisation and an industry or company you are likely to need to follow the industry collaboration framework and answer this question, check using the ICF decision tree . By ‘industry or company’ we mean an enterprise that puts goods or services on a market and whose commercial activities are greater than 20% of their overall annual capacity.
The assessors are looking for information relating to the nature, goals and conditions of the collaboration and any restrictions or rights to the project results that could be claimed by the project partner.
Find out more about ICF , including: definitions of basic or applied research internationally based companies Intellectual property (IP) arrangements fully flexible and gated contributions the ICF assessment criteria In addition to the project partner information completed in the previous section, confirm your answers to the ICF questions in the text box, and repeat this process for each ICF project partner: Name the industry or company project partner considered under ICF.
Indicate whether your application is either basic research or applied research. Explain why, in the absence of the requested UKRI funding, the collaboration and the planned research could not be undertaken. State whether your application is under the category of either fully flexible contribution or gated contribution (based on the IP sharing arrangements with the ICF partner).
Outline the pre-existing IP (‘background IP’) that each project partner (including the academic partner) will bring to the collaborative research project and the terms under which project partners may access these assets.
Outline the IP that is expected to be developed during the collaborative research project (‘foreground IP’) and briefly outline how it will be managed, including: which project partners will own this IP what rights project partners will have to use academically-generated foreground IP during and after the research project, for internal research and development or for commercial purposes any rights of the academic partner to commercialise the foreground IP (including foreground IP generated by project partners) Outline any restrictions to dissemination of the project results, including the rights of the project partner to: review, approve or delay publications (including the time period associated with such rights) request or require the removal of any information Declare any conflicts of interest held by the applicants in relation to the project partners and describe how they will be managed.
If applicable, justify collaborating with an overseas industry or company under ICF. Failure to provide the information requested for industry partners under ICF could result in your application being rejected. You are recommended to discuss the goals and conditions of any collaboration with an industry or company project partner with your university technology transfer or contracts office before applying.
Ethics and responsible research and innovation (RRI) What are the ethical or RRI implications and issues relating to the proposed work? If you do not think that the proposed work raises any ethical or RRI issues, explain why.
What the assessors are looking for in your response Demonstrate that you have identified and evaluated: the relevant ethical or responsible research and innovation considerations how you will manage these considerations Consider the MRC guidance on ethics and approvals You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.
Research involving human participation Will the project involve the use of human subjects or their personal information? What the assessors are looking for in your response If you are proposing research that requires the involvement of human subjects, provide the name of any required approving body and whether approval is already in place. Justify the number and the diversity of the participants involved, as well as any procedures.
Provide details of any areas of substantial or moderate severity of impact. If this does not apply
According to the current listing, eligibility includes: Eligible groups and individuals conducting research relevant to the MRC, including individuals from MRC units and the Francis Crick Institute. Confirm the full requirements in the official notice before applying.
The current listing shows up to £150,000 (MRC contribution) for a maximum of 18 months. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Public Health Intervention Development Scheme (PHIND) is funded by Medical Research Council (MRC). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleDARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read articleOn June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read article